Quantcast
Last updated on April 18, 2014 at 10:08 EDT

Latest Bone density Stories

2011-03-23 15:06:00

THOUSAND OAKS, Calif., March 23, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced new long-term data showing that during the fourth and fifth years of Prolia® (denosumab) treatment, postmenopausal women with osteoporosis receiving Prolia continued with further, statistically significant, year-over-year increases in lumbar spine and total hip bone mineral density (BMD), a key measurement of bone strength. The overall adverse event profile was similar for the...

2011-03-23 15:05:00

THOUSAND OAKS, Calif., March 23, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced new data that showed postmenopausal women with osteoporosis had significantly greater adherence, compliance, and persistence during Prolia® (denosumab) treatment than during alendronate treatment, an oral bisphosphonate commonly used to treat osteoporosis. Adherence to treatment, which includes both compliance (a measure of how well patients follow directions for taking...

2011-02-25 08:40:38

By: Rhonda Craig, Ivanhoe Health Correspondent (Ivanhoe Newswire) -- The same medicines used to treat angina and chronic heart failure, may also help treat osteoporosis. In this new study, researchers found that postmenopausal women that used nitroglycerin ointment for two years experienced a modest increase in bone mineral density and decrease in bone loss. According to study authors, the number of osteoporotic fractures is increasing, and an inexpensive and widely available treatment like...

2011-02-23 01:50:42

Older women who used bisphosphonates (medications that prevent loss of bone mass) for five years or more were more likely to experience "atypical" fractures involving the femoral shaft (bone in the leg that extends from the hip to the knee) or subtrochanteric (fractures in the bone just below the hip joint), compared to women with less usage. However, the absolute risk of these "atypical" fractures was low and bisphosphonate use was associated with a reduced risk of typical osteoporotic...

2011-02-23 01:46:39

Preliminary research indicates that use of nitroglycerin ointment among postmenopausal women for 2 years was associated with a modest increase in bone mineral density and decrease in bone resorption (loss), according to a study in the February 23 issue of JAMA. "The number of osteoporotic fractures is increasing worldwide as populations age. An inexpensive and widely available treatment may help limit this increase," the authors write. "Nitroglycerin stimulates bone formation and inhibits...

2011-02-16 08:13:12

By Rhonda Craig, IBN Health Correspondent (Ivanhoe Newswire) -- Pediatric Implants designed to help heal broken bones, may actually be damaging the very bones they were intended to treat. According to new research from Johns Hopkins Children's Center, children with hip and thigh implants are at a greater risk of experiencing bone fractures at the area of the implant. For the study, researchers analyzed more than 7,500 pediatric bone implant procedures at Johns Hopkins. They found that nine...

2011-02-02 13:13:59

Researchers say breast cancer therapy contributes to early-in-life hip fractures A hip fracture is not common in a 54-year-old woman, unless she is a 54-year-old breast cancer survivor, according to a new Northwestern Medicine study. Researchers found that a combination of early menopause due to breast cancer treatment and common drugs used to treat breast cancer, could be weakening the bones of breast cancer survivors once they hit middle age, leading to hip fractures. Results of the study...

2011-02-01 17:49:02

Elsevier announced today the publication of two further important position statements from the European Menopause and Andropause Society (EMAS) in the journal Maturitas (http://www.maturitas.org/ ) on common management problems in the post-reproductive health of women. EMAS is providing clear guidance in its position statements covering both hormone and non hormone therapy (HT) options as well as complementary and alternative therapies . The latest two position statements cover the management...

2011-01-25 11:55:24

Recommendations provide diagnosis, treatment guidance for postmenopausal women The American Association of Clinical Endocrinologists (AACE) has released new medical guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Loyola physician Pauline Camacho, MD, was part of a committee that developed the guidelines to manage this major public health issue. These recommendations were developed to reduce the risk of osteoporosis-related fractures and improve the quality of life...

2011-01-17 16:00:00

ROCKVILLE, Md., Jan. 17, 2011 /PRNewswire-USNewswire/ -- In an update to its 2002 recommendation, the U.S. Preventive Services Task Force (USPSTF) now recommends that all women ages 65 and older be routinely screened for osteoporosis. This is the first final recommendation statement to be published since the USPSTF implemented a new process in July 2010 in which all of its draft recommendation statements are posted for public comment on the USPSTF website prior to being issued in final...